The test is authorized to assess the serum, plasma or urine of individuals who meet the CDC’s clinical or epidemiologic criteria for Zike testing.
While the test has not earned FDA approval, the agency will permit the test’s use as long as Zika remains a national public health concern.
The agency previously provided emergency use authorizations for several other Zika diagnostic tests within the past few months to control the spread of the virus.
More articles on supply chain:
Intermountain Healthcare recognizes 4 suppliers for outstanding work
Mylan working on EpiPen formulation with longer shelf life
FDA fast tracks malaria vaccine
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
